Publications by authors named "Jennifer A Grabowsky"

Claim this Profile
D
Differential Toxicity in Patients with and without DNA Repair Mutations: Phase I Study of Carboplatin and Talazoparib in Advanced Solid Tumors.
Mallika S Dhawan, Imke H Bartelink, Rahul Raj Aggarwal, Jim Leng, Jenna Z Zhang, Jennifer A Grabowsky

Clin Cancer Res· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I dose-escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC-223 in patients with advanced solid tumors or multiple myeloma.
Johanna C Bendell, Robin K Kelley, Kent C Shih, Jennifer A Grabowsky, Emily Bergsland

Cancer· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors.
Adil I Daud, Michelle T Ashworth, Jonathan Strosberg, Jonathan W Goldman, David Mendelson, Jennifer A Grabowsky

J Clin Oncol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug interactions and the pharmacist: focus on everolimus.
Jennifer A Grabowsky

Ann Pharmacother· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis